When it comes to testing, many health systems limit their approach to focus on specific disease stages or cancer types. This strategy might be a way to fall behind as precision medicine advancements evolve. 

To make personalized cancer care more accessible, organizations may consider effectively leveraging genomic testing, which can help identify potential clinical trial options and inform treatment alternatives.

This brief report outlines some ways organizations may make genomic testing more accessible to physicians and patients keeping cost-effectiveness and patient outcomes top of mind. 

Key learning points:

• Designing a comprehensive genomic testing program that could expand patients' access to cutting-edge care & improve financial results
• Persistent challenges that prevent change and potential ways to address them
• Good practices to integrate genomic testing into care pathways